HTB homepage • Conference reports • Articles by subject • Subscribe June 2026 Contents Conference reports BHIVA 2026: Chemsex data, service needs and how health workers can help Antiretrovirals FDA and EMA applications to expand dolutegravir indication to newborns from birth Once-weekly oral islatravir/lenacapavir meets 48-week primary endpoint in phase 3 studies Treatment strategies New guidelines on persistent low-level viral load in people living with HIV (2026) Treatment access CHAI reports impact of cuts in HIV, CD4 and viral load testing, reduced PrEP: children fare worst PK and drug interactions Important drug interactions between HIV drugs and encorafenib and dabrafenib Coinfections and complications UKHSA continues to recommend 4CMenB vaccine against gonorrhoea in gay men HTB homepage • Conference reports • Articles by subject • Subscribe
